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ABSTRACT 65 
Peripheral artery disease (PAD) is caused by atherosclerotic narrowing of the arteries supplying 66 
the lower limbs often resulting in intermittent claudication, evident as pain or cramping whilst 67 
walking.   68 
Supervised exercise training elicits clinically meaningful benefits in walking ability and quality 69 
of life. Walking is the modality of exercise with the strongest evidence and is recommended in 70 
several national and international guidelines. Alternate forms of exercise such as upper or 71 
lower-body cycling may be used, if required by certain patients, although there is less evidence 72 
for these types of programmes. The evidence for progressive resistance training is growing and 73 
patients can also engage in strength-based training alongside a walking programme. For those 74 
unable to attend a supervised class (strongest evidence), home-based or “self-facilitated” 75 
exercise programmes are known to improve walking distance when compared to simple advice.  76 
All exercise programmes, independent of the mode of delivery, should be progressive and 77 
individually prescribed where possible, considering disease severity, comorbidities and initial 78 
exercise capacity. All patients should aim to accumulate at least 30 minutes of aerobic activity, 79 
at least three times a week, for at least 3 months, ideally in the form of walking exercise to near 80 
maximal claudication pain. 81 
 82 
Key Words: Peripheral Arterial Disease, Exercise, Intermittent Claudication  83 
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SUMMARY BOX  84 
  85 
WHAT IS ALREADY KNOWN: 
• Supervised exercise training promotes clinically meaningful benefit in 
patients with intermittent claudication. 
• Walking as an exercise modality currently has the strongest level of evidence 
WHAT THIS STUDY ADDS: 
• A concise summary of evidence and practical recommendations for 
exercise implementation for practioners, including example protocols for 
exercise training.  
• Progressive resistance training may be used as a supplement to walking 
programmes.  
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INTRODUCTION 86 
Lower-limb peripheral artery disease (PAD) is an atherosclerotic cardiovascular disease in 87 
which the arteries that carry blood to the legs and feet become hardened, narrowed and/or 88 
obstructed by the build-up of atheroma.1 PAD is a common problem thought to affect over 200 89 
million people worldwide.2 The total disease prevalence is approximately 13% of adults >50 90 
years old, with major risk factors including smoking, diabetes and dyslipidaemia.3  91 
The most classic symptom of PAD is intermittent claudication (IC). This is ischaemic muscle 92 
pain that usually presents in the calves (but can include the thighs or buttocks), is precipitated 93 
by exertion and relieved with rest (Figure 1).4 This pain is thought to be due to a mismatch 94 
between the oxygen demand (of the working muscle) and an inadequate blood supply (due to 95 
the narrowed arterial pathway).5 96 
Although PAD is progressive (in the pathological sense), the clinical course is relatively 97 
stable.6 However, patients with PAD have higher a burden of cardiovascular disease and are at 98 
greater risk of major cardiovascular events.7 Another major issue for many patients is the severe 99 
decline in functional capacity (V̇O2Peak) which are comparable to patients with heart failure and 100 
reduced ejection fraction.8 The reduction in functional capacity is commonly caused by a 101 
decline is in walking capacity; which may be up to less than 50% of healthy aged-matched 102 
controls.9 Factors influencing the walking distance or speed at which symptoms occur are 103 
multifactorial and include the site and severity of disease, walking pace, terrain, incline and 104 
footwear.10 These physical constraints in turn have negative connotations on patient’s mental 105 
health and there are strong associations with depression, poor quality of life (QoL) and further 106 
avoidance of physical activity.11,12 This cycle of activity avoidance only leads to worsening 107 
functional ability and there is some evidence to suggest it also leads to  an elevated mortality 108 
risk independent of disease severity and age.13 109 
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Treatment for patients with IC involves secondary prevention of cardiovascular disease risk, 110 
including smoking cessation, diet changes, lipid modification and statin therapy, antiplatelet 111 
therapy, and management of diabetes and hypertension.  In addition to therapeutic intervention 112 
and lifestyle modification, the primary treatment to address the functional impairment outlined 113 
above is for patients to engage in appropriate exercise training, best achieved through a 114 
supervised exercise programme.14 This is supported by multiple consensus guidelines from 115 
various governing bodies.15 16 17 .18  However, they lack detail and consistency (between 116 
guidelines) as to the appropriate principles of exercise such as intensity and progression (table 117 
one), which impacts upon effective implementation. In addition to inconsistencies in the 118 
recommendations for exercise, there is also variability in the delivery of exercise programmes 119 
globally with some clinicians reporting lack of expertise or support to guide the exercise 120 
delivery 19-21.  121 
This guideline for practitioners therefore aims to accompany these consensus guidelines to 122 
provide a succinct but more detailed overview of, and recommendations for, exercise 123 
prescription and training for IC. Whilst we appreciate that delivery and provision will vary, the 124 
key exercise prescription components will remain and as such, this document will be relevant 125 
for exercise practioners worldwide. In addition, we provide advice for the implementation of 126 
the exercise prescription guidelines into clinical practice (table two), which also includes 127 
information on structured alternatives when SEPs are not available 19,22  128 
Walking ability  129 
Measures of walking ability include pain-free and maximum-walking distance (or time) 130 
obtained during standardised treadmill testing and /or the distance covered in the 6-minute 30-131 
meter corridor walk test. Several treadmill protocols have been reported, but the 132 
‘Gardner/Skinner’ incremental protocol is most commonly used.23,24 This involves a constant 133 
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speed of 3.2 km/h at a 0% grade, increasing by 2% every 2 minutes. The advantage of using a 134 
treadmill test is that it can be standardized (i.e speed of treadmill, grade of treadmill), although 135 
it is may not be as reflective of normal everyday walking (6-minute walking distance)25,26.  136 
Quality of life  137 
Several generic and condition-specific questionnaires have been used to assess QoL. The most 138 
validated, responsive and reliable questionnaires in the IC population are the Short-Form-36 139 
(SF-36) and King’s College Hospital’s VascuQol questionnaires, respectively.27,28 Additional 140 
and commonly used questionnaires include the Walking Impairment Questionnaire29 and the 141 
Peripheral Artery Questionnaire30. 142 
EXERCISE TRAINING 143 
Benefits of exercise training 144 
A recent Cochrane review concluded that there is high-quality evidence showing that 145 
supervised exercise programmes (a variety of regimes) elicit important improvements in both 146 
pain-free and maximum-walking distance compared with no-exercise control in people with 147 
IC14. A meta-analysis of 9 trials (n=391) showed a mean between-group difference in pain-free 148 
walking distance at follow-up of 82 m (95% CI 72–92 m; (follow-up ranging 6 weeks to 2 149 
years) and maximum walking distance of 120 m (95% CI 50.79-190 m). The most commonly 150 
tested mode of exercise was walking, with one cycling intervention. The corresponding 151 
difference for maximum walking distance was 120 m (95% CI 51–190 m; 10 trials, n=500). 152 
Improvements of this magnitude are likely to represent clinically meaningful changes in 153 
ambulatory function.31  154 
The same review also reported that there was moderate-quality evidence for improvements in 155 
physical and mental aspects of QoL, assessed using the SF-36.14 A meta-analysis of data at 6 156 
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months follow-up showed the physical component summary score to be 2 points higher in 157 
exercise versus control (95% CI 1 to 3; 5 trials, n=429). The corresponding difference for the 158 
mental component summary score was 4 points (95% CI 3 to 5; 4 trials, n=343). Such 159 
differences have the potential to be clinically meaningful.14  160 
Modes of exercise 161 
In most studies, supervised exercise programmes have involved treadmill or track walking at 162 
an intensity that elicits moderate to maximal claudication pain.32 There is a strong evidence-163 
base for this type of training, and clinical guidelines cite it as the preferred modality (e.g., 164 
TASC II).15 As of 2011, alternate exercise modalities had not been extensively studied33. In 165 
2005, a randomised trial of 104 participants provided evidence that a 24-week intervention of 166 
either cycling or arm-cranking are viable alternatives for improving maximum walking 167 
distance (shuttle-walk) up to 29% and 31% respectively.34 These modalities may be most useful 168 
for patients who are unwilling/unable to walk because of severe pain or deconditioning.35 169 
Resistance training may also have a complementary role (e.g., for improving muscular 170 
strength)36; however, at this point, international guidelines suggest it should not be used as a 171 
substitute for aerobic exercise because its impact on walking distance appears modest (e.g., 172 
McDermott et al 2009). Nevertheless, there is emerging evidence to support its efficacy, and it 173 
should no longer be a mode of exercise that is ignored. A recent systematic review and meta-174 
analysis (n=826; 363 resistance trained) demonstrated that resistance training (in comparison 175 
to control) can significantly improve both maximum walking distance via constant treadmill 176 
testing (SMD 0.51 [95% CI 0.23-0.79]) and maximum walking distance via progressive 177 
treadmill testing (SMD 0.45 [95% CI 0.08-0.83]. Only six-minute claudication onset time (not 178 
pain-free treadmill distance) was significantly improved with resistance training (MD 82m 179 
[95% CI 40.91-123.54).36 180 
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Frequency of exercise 181 
A comparison of different training frequencies for patients with IC has not been investigated 182 
in a single study. The 1995 meta-analysis of Gardner and Poehlman suggested that an exercise 183 
frequency of ≥3 sessions per week was associated with better outcomes compared with <3 184 
times per week, although it should be noted that it pooled data from randomised controlled 185 
trials and uncontrolled studies.37 In addition, the 2004 review of Bulmer and Coombes also 186 
identified 3 sessions per week as the optimal frequency for maximum improvements in walking 187 
distance.38 Conversely, a meta-analysis in 2012 including 1054 patients did not identify an 188 
optimal frequency for programmes39. The authors of the 2012 meta-analysis do note however, 189 
that a SEP with three sessions per week (in combination with duration of programme and 190 
session) “would give the best results”.39 Therefore, frequency of supervised exercise 191 
programmes should aim be at least three times per week, which is in line with common physical 192 
activity guidelines for the general population.17 193 
Duration of programme 194 
No standardised duration of programme for patients with IC has been identified, with exercise 195 
programme length ranging from as little as 2 weeks to as many as 18 months.32 Gardner et al 196 
(2012) measured outcomes at 2, 4 and 6 months (n = 80) and demonstrated that exercise-197 
mediated improvements in pain-free and maximum walking distances were largely achieved in 198 
the first 2 months.40 Additional meta-analysis have also demonstrated that improvements in 199 
treadmill walking occur following 3 months of supervised exercise38,41,42.  It may be likely that 200 
the optimal prescription is difficult to elucidate due to heterogeneity of studies, including 201 
differences in frequency, intensity and type of the exercise. Currently we recommend that 202 
programmes should be at least a minimum of 12 weeks in duration. 203 
 204 
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Intensity of exercise 205 
Exercise intensity is commonly prescribed on the basis of heart rate, rating of perceived 206 
exertion, or V̇O2peak obtained via exercise stress testing,43 and may be classified as low, 207 
moderate or vigorous based on American College of Sports Medicine guidelines.44 There is 208 
limited information on the appropriate intensities of exercise programmes for patients with 209 
PAD.17,45 However, a meta-analysis by Parmenter et al (2015) investigated the relationship 210 
between exercise intensity, V̇O2peak (i.e. aerobic capacity), and maximal walking distance and 211 
demonstrated that the greatest improvements occurred when exercise intensity was between 212 
70-90% HRmax (i.e. vigorous according to the American College of Sports Medicine 213 
guidelines.46 A further systematic review by Pymer et al (2019) focusing on high-intensity 214 
exercise identified four studies that prescribed exercise on the V̇O2peak or HRmax achieved 215 
during baseline testing. Overall (six studies) demonstrated significant improvements in 216 
treadmill maximum walking distances compared to a control group (generally consisting of 217 
exercise advice alone).47 However, further research is required to establish the relationship 218 
between intensity (moderate versus vigorous) and walking improvements and compare those 219 
findings to supervised exercise programmes. 220 
Claudication pain scale 221 
Relatively few trials have used classically defined measures of exercise intensity as described 222 
above and for patients with PAD there is a common misconception between exercise 223 
“intensity” and severity of leg pain or discomfort.48 Most reported trials in the literature utilise 224 
the claudication pain scale to instruct patients when to stop exercising and not exercise intensity 225 
markers such as heart rate. The claudication pain scale is a continuous scale from 1, indicating 226 
no pain, to 5 indicating severe pain,46 with trials often instructing patients to walk to near-227 
maximal pain levels.  228 
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Three studies have specifically investigated the relationship between “intensity” (based on 229 
pain) and walking outcomes.49-51 Mika et al (2013) utilised different intensities corresponding 230 
to scores on the pain scale and matched exercise duration in 60 patients.50 Gardner et al (2005) 231 
prescribed intensity as “high – 80%” or “low – 40%” based on the maximal grade achieved at 232 
baseline in 31 patients.52 Finally, Novakovic et al (2019) randomised 36 patients to either 233 
moderate or pain-free walking, with moderate training prescribed on 70% of the patients 234 
predicted HR max.51 For all studies, outcomes including pain-free and maximum walking 235 
distance did not differ between the intensities prescribed. This may highlight that the volume 236 
of exercise (and not intensity prescribed) is perhaps the most important factor for improving 237 
walking distance in patients with IC.33,46,53 With regard to pain, overall the current evidence 238 
seems to favour patients walking near maximal pain for beneficial outcomes. However, 239 
walking to no pain, or minimal pain, may also been shown to be effective for this cohort.51,53 240 
Indeed, a meta-analysis by Parmenter et al (2011) showed that walking without inducing 241 
claudication pain produced significant improvements in initial claudication distance and also 242 
improved absolute claudication distance.33 Additionally, a meta-analysis (six studies) in 2015 243 
demonstrated that improvements in cardiorespiratory fitness were obtained when walking to 244 
mild pain (MD 0.79 ml/kg/min-1 [95% CI 0.45-1.14]).46 Current recommendations are if 245 
patients can tolerate, then walking to moderate pain (i.e 4-5 on the claudication scale) may be 246 
suitable. If patients are unable to tolerate higher levels of pain on the claudication scale, then 247 
they can walk to low levels of pain, provided the volume of exercise is sufficient,44 which may 248 
improve adherence levels.  249 
Supervision 250 
Despite consistent evidence demonstrating the clinical effectiveness of supervised exercise 251 
programmes, a European survey conducted in 2012 demonstrated that approximately 30 % of 252 
respondents had access to a supervised programme,54 with similar availability in the UK.19 253 
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Similar evidence has recently emerged from America with 54 % of respondents stating no 254 
exercise to a supervised exercise programme.20 These low provision rate may be attributed to 255 
several factors including funding provision, facilities, referral pathways, resources and a lack 256 
of trained staff.19,55 257 
A 2014 review noted uncertainty regarding the benefits of supervised exercise programmes 258 
over unsupervised exercise, especially regarding QoL.48 Despite the apparent superiority of 259 
supervised exercise programmes, there is still a need to develop alternative programmes, given 260 
that supervised programmes may be “unpopular” with patients due to financial, time or 261 
transport limitations,56,57 or simply because they are looking for a “quick fix”.58 As supervised 262 
programmes may be unavailable to a large proportion of patients, the development of 263 
alternative home-based or “self-facilitated” programmes have been increasingly trialled. These 264 
types of interventions have varied in content but include; psychological interventions,59 such 265 
as cognitive behavioural changes,60 step-monitoring,61 and patient education.62 266 
Home exercise programmes 267 
Evidence for home-based or self-managed programmes is currently conflicting. In 2013, a 268 
systematic review reported that there was low-level evidence to suggest home-based 269 
programmes can improve walking distance and QoL in comparison to walking advice or non-270 
exercise.63 In 2018, a Cochrane review including 21 studies and 1400 patients, reported that 271 
there was high-quality evidence showing greater improvements in maximum walking distance 272 
(measured via treadmill testing) at three months amongst patients enrolled in a supervised 273 
exercise programme versus a home-based programme (95% CI 0.12 – 0.65), or in patients who 274 
received walking advice only (95% CI 0.53 – 1.07).64 This translates to walking distance 275 
improvements of between 120-210 m in favour of supervised exercise, respectively, with 276 
similar improvements maintained at 6 and 12 months. However, the prescription of exercise 277 
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may influence the magnitude of effect, possibility due to training specificity.46. Conversely, 278 
meta-analysis of QoL outcomes showed no marked differences between supervised exercise 279 
and home exercise programmes. In a recent randomised trial, McDermott et al (2018) 280 
considered the efficacy of home-based exercise (n = 99) with wearable technology and 281 
telephone coaching vs no exercise advice and found no difference home exercise and control.65 282 
Therefore, further research is required to evaluate the specific components of home-based 283 
interventions to maximise patient benefit (i.e. wearable technology, on-site visits etc). 284 
Safety 285 
There may be a misconception that exercise training may be unsafe in patients with PAD.  286 
Indeed, 70% of vascular surgeons in one survey thought that cardiovascular comorbidities or 287 
aorto-iliac stenosis or occlusions were relative contraindications to exercise.66 Gommans et al 288 
(2015) explored the safety of supervised exercise training (via any exercise modality) and 289 
reviewed adverse event data from clinical trials.67 Seventy-four trials were included, 290 
representing 82,725 hours of training in 2,876 patients with a mean age of 64 (range 54-76). 291 
Eight adverse events were reported, six of cardiac and two of non-cardiac origin and one fatal 292 
adverse event (myocardial infarction). This resulted in an all-cause complication rate of one 293 
event per 10,340 patient-hours. The total non-cardiac and cardiac event rate was one per 13,788 294 
patients and one per 41,363 hours. The study concluded that supervised exercise training is 295 
safe for people with IC due to a low all-cause complication rate, and routine cardiac pre-296 
screening is not required.67 However, it should be noted that patients participating in clinical 297 
trials might not be a true representation of the overall population. This may be due to strict 298 
exclusion / inclusion criteria screening out patients with extensive co-morbidities. It would be 299 
beneficial to have observational data for adverse events in routine supervised exercise 300 
programmes, to fully elucidate the all-cause complication rates. In addition, it is important to 301 
note, that as a patient’s exercise tolerance, pain tolerance and walking ability improve, this may 302 
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begin to unmask underlying signs and symptoms of coronary artery disease. Whilst not routine 303 
practice, cardiac screening may also be considered when patients are engaging in an exercise 304 
modality that may not elicit claudication pain such as cycling or when they are engaging in 305 
higher intensity exercise programmes. In general, contra-indications to participation in an 306 
exercise programme include uncontrolled hypertension, unstable angina or other uncontrolled 307 
arrhythmias. Relative contraindications include known obstructive coronary disease, acquired 308 
or advance heart block. A comprehensive list of both absolute and relative contraindications 309 
can be found in the ‘American College of Sports Medicine Guidelines for Exercise Testing and 310 
Prescription’.44,68 311 
APPLICATION TO PRACTICE  312 
Recommendations for Exercise Training 313 
All prospective patients should be clinically assessed, and risk stratified to ensure that they do 314 
not have any contraindications to the exercise therapy, and to document comorbidities that may 315 
need to be accounted for, in order to individualise the exercise programme. Patient ability and 316 
preference should also be taken into account when prescribing the exercise programme. 317 
Clinical assessment should be repeated as exercise tolerance improves to ensure that the 318 
training intensity is sufficient to ensure ongoing patient safety.  Any exercise programme 319 
should ideally be delivered through an on-site supervised programme with clinical oversight. 320 
However, a facilitated, self-managed exercise programme involving behaviour change 321 
techniques is a reasonable alternative for patients who prefer this approach or are unable to 322 
access supervised exercise.62 The core modality for supervised exercise programmes should be 323 
walking, however, other modes are also efficacious for those who cannot tolerate walking 324 
programmes, as outlined in table two. Alternative modes include arm cranking, cycling, pole-325 
striding, and progressive resistance training. A structured programme should involve walking 326 
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at an intensity that elicits moderate-to-strong claudication pain and should be conducted for a 327 
minimum of 3 months, involving at least three, 30-45-minute sessions per week. Initial exercise 328 
prescription should be based on actual baseline maximum walking distance. Further evidence-329 
based recommendations for exercise training are provided in Table 1. However, if patients 330 
struggle with the maximum intensity of pain prescribed, then walking at lower pain levels will 331 
also lead to improvements in walking ability/distance.33,53  332 
During exercise training sessions, acute responses to exercise should be monitored to inform 333 
the exercise prescription, including heart rate, blood pressure (in the first few exercise 334 
sessions), perceived exertion, and claudication pain. The continuous monitoring of blood 335 
pressure is not recommended but should be revaluated if the intensity or mode of exercise 336 
changes. It is recommended that heart rate may be monitored continuously and blood pressure, 337 
perceived exertion and claudication pain are recorded intermittently when the patient stops 338 
exercises (if interval walking) or if any signs or symptoms (such as dizziness are present). 339 
Finally, programme entry and exit assessments should be performed to determine changes in 340 
patient outcomes, including walking distance (primarily 6-minute walk test) and QoL.  341 
To support the provision and uptake of exercise, alongside this guideline an infographic of key 342 
messages has been developed that may be used as a poster or handout in clinic; particularly 343 
where patients cannot access a supervised programme69.  344 
 345 
 346 
347 
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SUMMARY  348 
Exercise training is a safe, effective and low-cost intervention for improving walking ability in 349 
patients with IC. Additional benefits may include improvements in QoL, muscle strength and 350 
cardiorespiratory fitness. Clinical guidelines advocate supervised exercise training as a primary 351 
therapy for IC, with walking as the primary modality. However, evidence is emerging for the 352 
role of various other modes of exercise including cycling and progressive resistance training to 353 
supplement walking training. In addition, there is emerging evidence for home-based exercise 354 
programmes. Revascularisation or drug treatment options should only be considered in patients 355 
if exercise training provides insufficient symptomatic relief. 356 
  357 
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FIGURE LEGENDS  564 
Table One. Vascular Surgery Guideline Recommendations for Exercise. 565 
Table Two: Summary of Exercise Prescription Recommendations 566 
Figure 1. Intermittent claudication due to peripheral artery disease. Reproduced from 567 
Peripheral Artery Disease, (3) with permission from BMJ Publishing Group Ltd. Note: 568 
Iliac or femoral artery disease can cause symptoms at multiple distal muscle sites. 569 
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Table One: Vascular Surgery Guideline Recommendations for Exercise  570 
Recommendation Frequency Intensity Type Time Duration Progression Supervision Location Supplementary 
exercises  
Guideline          
TASC II, 2007 15 3 x per week 
(typically) 
Speed and 
grade that 
induces 
claudication 
within 3-5 
minutes.  
Intermittent 
treadmill 
walking 
30 minutes 
increasing 
up to 60 
minutes 
Not 
reported 
Increase 
speed / grade 
if patient can 
walk for 
more than 10 
minutes 
Not reported  Not 
reported 
Not reported   
AHA / ACC, 
201617 
3 x per week  Maximum-
moderate 
claudication 
Intermittent 
walking 
30 – 45 
minutes 
per 
session, 
with warm 
up and 
cool down 
Minimum 
of 12 
weeks 
Not reported  Supervised 
by a 
qualified 
healthcare 
professional 
Hospital / 
outpatient 
facility 
Not reported  
ECS, 201718  Not reported Not reported  
 
Walking Minimum 
3h/week 
At least 3 
months 
Not reported Supervised Not 
reported 
Cycling, 
strength training 
and upper-arm 
ergometry 
NICE 147,201816  Not reported Maximal 
pain 
Walking 2h/week 3 months Not reported Supervised Not 
reported 
Not reported 
RACGP, 201370 3-5 x p/w Pain Intermittent 
walking 
30 minutes 
increasing 
to 60 
minutes 
Not 
reported 
Not reported Supervised Not 
reported 
Not reported  
 571 
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Table Two: Summary of Exercise Prescription Recommendations 572 
Exercise 
rationale 
To improve walking capacity, claudication symptoms and quality of life, and for secondary 
prevention of cardiovascular disease 
Provider  The programme should have a designated clinical lead (e.g. vascular surgeon, physician or 
nurse specialist).  Exercise professionals who wish to work in this area should possess the 
essential competencies and minimum qualifications as per the country of work. Professional 
standards of accredited exercise physiologists should include detailed knowledge of 
pathophysiology, exercise physiology and exercise training for patients with IC. Some of this is 
specified in the following BACPR Position Statement (UK 
Based):http://www.bacpr.com/resources/51A_EPG_Position_Statement.pdf  
Mode of 
delivery 
The exercise should ideally be delivered through an on-site supervised programme. The exercise 
prescription should be individually-tailored based on an initial assessment; however, several 
patients may be supervised at the same time. A facilitated, self-managed exercise programme 
with embedded behaviour change techniques is a reasonable alternative for people who prefer 
this approach or are unable to access an on-site programme, or for longer-term benefit after a 
supervised programme is completed. Details of a structured education programme that promotes 
self-managed walking exercise can be found here62. Additional information for home-based 
exercises can be found here (https://circulationfoundation.org.uk/news/covid-19-special) 
Unstructured, unsupervised exercise approaches that consist solely of basic advice to walk 
or exercise more are not effective. 
Setting On-site programmes can be delivered in various settings including hospital- or community-based 
exercise physiology or physiotherapy clinics or community exercise facilities. Self-managed 
programmes can be conducted in a setting that suits the individual. 
Materials Assessment tools: Motorised treadmill with adjustable incline to allow incremental exercise 
testing (e.g. ‘Gardner’ protocol) to determine pain-free and maximum walking distances or, if 
unavailable, procedures and instructions for an alternative functional capacity test (e.g. 30 meter 
6-minute corridor walk test); questionnaires for assessing patient-perceived ambulatory function 
(e.g. WELCH questionnaire), and generic and condition-specific quality of life (e.g. SF-36, 
VascuQol and Walking impairment questionnaires, respectively). Optional – equipment to assess 
vascular status (e.g. ankle-brachial index) and cardiovascular disease risk (e.g. blood pressure, 
lipid profile).  
Exercise equipment: Motorised treadmills with adjustable incline or space for over-ground 
walking (preferably indoor and air-conditioned). Optional for aerobic exercise – upper and lower 
limb ergometers. Optional for resistance exercise – weights machines, dumbbells. 
Intensity-monitoring equipment: 5-point claudication pain scale, exertion scale (e.g. 6‒20 
point Borg Rating of Perceived Exertion Scale), heart rate monitors, manual sphygmomanometer 
and stethoscope.  
Walking 
exercise 
guidelines 
Programme duration: At least 3 months  
Frequency: ≥3 times/week  
Claudication pain endpoint: Based on current evidence, patients should be advised to walk to 
the point of near-maximum leg pain (i.e. 4-5 on claudication pain scale); however, preliminary 
evidence suggests that walking only to the onset of ischemic leg pain may also be beneficial for 
patients reluctant to walk at higher levels of pain 
Pattern: Following a warm-up period, the patient should walk at a speed and grade that induces 
claudication pain within 3-5 minutes. The patient is instructed to stop walking and rest when his 
or her claudication pain reaches a moderate-to-strong level. When the claudication has abated, 
the patient resumes walking until a moderate-to-strong claudication pain recurs. This cycle of 
exercise and rest is ideally repeated for at least 30 minutes. In subsequent visits, the speed or 
Exercise Training for Intermittent Claudication 
 
 
26 
grade of walking is increased if the patient is able to walk for ≥10 minutes without reaching 
moderate claudication pain. For those patients who start at a lower level of claudication pain (1-
3/5), as the patient tolerates it, they should be encouraged to increase the intensity of pain 
achieved as a progression tool.  
Duration per session: Many patients with IC may need to start with just 10-15 minutes of 
walking exercise per session. In this situation, the duration of exercise should be increased by 5 
minutes each week, until the patient is walking for at least 30 minutes per session. Patients who 
can walk for more than 30 minutes per session should be encouraged to increase the exercise 
duration to 45-60 minutes. They should also be encouraged to include other modes of exercise to 
work on improving cardiorespiratory fitness and muscular strength 
Upper & 
lower limb 
ergometry 
May be considered as alternative aerobic exercise strategies for improving walking ability and 
quality of life. May also have the potential to provide a greater cardiorespiratory stimulus than 
walking exercise in individuals with severe claudication.  
Example protocol: Ten sets of 2 minutes of upper or lower extremity ergometry conducted twice 
weekly for at least 3 months. Intensity should be moderate or Borg RPE 13-14 (6-20 scale) 
Resistance 
exercise 
Though evidence is increasing, resistance exercise is yet to be included in international guidelines 
as a sole therapy, it is purely recommended as an adjunct for now. It therefore should be 
considered as complementary (e.g. for targeting improved strength or reduced falls risk), but not 
as a replacement for aerobic exercise because its impact on walking ability appears modest at 
best.  
Example protocol: Moderate-to-high intensity (Borg exertion rating of 14-16), 6-8 exercises 
(Leg press, Knee flexion, knee extension, calf press, chest press, seated row) targeting the major 
muscle groups of the upper and lower body, 2-4 sets of 10-15 repetitions per set, 2-3 sessions per 
week.  
Other Circuit-based training may be a practical way of delivering a combination of aerobic and 
resistance exercises when circumstances necessitate group-based training and is an effective tool 
for improving both muscle strength and cardiorespiratory fitness, which are both related to 
reduced cardiovascular and all-cause mortality 71.  
Safety issues An initial risk assessment should occur as per Appendix E of the following ACPICR Standards 
document https://www.acpicr.com/data/Page_Downloads/ACPICRStandards.pdf . Exercise is 
contraindicated by foot ulcers and limb pain at rest (i.e. critical limb ischaemia). As patients 
increase their walking ability, there is the possibility that cardiac signs and symptoms may 
appear (e.g., dysrhythmia, angina). These events should prompt further clinical assessment to 
ensure safety continuing. Clinical assessment should also be considered when a patient 
undertakes a mode of exercise that is not limited by claudication pain.  
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